US nod for Gilead’s pan-genotypic hep C pill

19th July 2017 Uncategorised 0

The US Food and Drug Administration has waved through Gilead’s new hepatitis C therapy Vosevi, offering adults with all genotypes of the condition a new treatment option in the form of three medicines in a single pill.

More: US nod for Gilead’s pan-genotypic hep C pill
Source: News